Jump to content

Search the hub

Showing results for tags 'Screening'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 166 results
  1. News Article
    Hundreds of people identified as contacts following a tuberculosis (TB) outbreak in a Carmarthenshire village are yet to attend a screening, health officials have said. Public Health Wales (PHW) said 31 cases of active TB had been identified since the 2010 outbreak in Llwynhendy. PHW urged the 485 people who have been identified as contacts, but not attended a screening, to act. More than 2,600 people have attended screenings since June 2019. TB is a bacterial infection, spread through inhaling tiny droplets from the coughs or sneezes of an infected person. It is a serious condition, but can be cured with proper treatment. PHW said since 2010, 303 people - or more than one in 10 of those who had been screened - had been diagnosed with latent TB, which is not infectious and does not affect a person's quality of life, but may develop into active TB at a later date. Dr Brendan Mason, from Public Health Wales, said: "We understand that during the coronavirus pandemic people may have been reluctant to go to a hospital to have their screening done, but I can assure them that there are safety measures in place in order to prevent the spread of Covid-19. "Now is the time to get tested. "It is really important that we screen all the contacts identified and make sure that anyone diagnosed with latent or active TB gets the monitoring or treatment that they need to prevent any further spread." Read full story Source: 24 February 2022
  2. Content Article
    This guide by The Eve Appeal and The Survivors Trust outlines some simple actions healthcare professionals can take to make cervical screening appointments easier for patients and service-users who are survivors of rape or sexual abuse. It is part of the #CheckWithMeFirst campaign to help raise awareness of the challenges survivors of rape, sexual abuse and sexual violence may face when accessing cervical screening. They have also produced a cervical screening guide for survivors of rape, sexual abuse or assault, which can be found on the hub here.
  3. Content Article
    This guide by The Eve Appeal and The Survivors Trust gives information about attending cervical screening for survivors of rape, sexual abuse or assault. It offers tips that may help patients feel more comfortable about their appointment. It is part of the #CheckWithMeFirst campaign to help raise awareness of the challenges survivors of rape, sexual abuse and sexual violence may face when accessing cervical screening.
  4. News Article
    Two years of the pandemic have meant drops in essential screening and detection in Australia, while cancer patients undergo treatments alone and isolate to avoid Covid risks. When Claire Simpson turned 50 in early 2020, she received a letter telling her to get a mammogram. Then the pandemic hit, and Victoria went into lockdown. “Like many people, I put it off until we were coming out of that lockdown, but by then it was September and I couldn’t get an appointment until December,” she says. In February 2021 she was diagnosed with breast cancer and had a mastectomy. Tests showed she was positive for the aggressive HER2 receptor, so she began 12 weeks of chemotherapy as well as a treatment called Herceptin, which she received an IV infusion of every three weeks. Simpson says the delay in screening “really, really delayed diagnosis for me, by a good six months”. “I can’t help but feel that [an earlier screening] could have probably saved me from having to have chemotherapy and this Herceptin infusion therapy that I’m having,” she says. Her last Herceptin treatment was last Wednesday. She has been living in self-imposed lockdown, terrified as the Omicron wave built that she would have to isolate due to Covid and disrupt her treatment. That self-imposed isolation will continue until her final surgery, an elective operation scheduled for mid-year. Cancer screening dropped by 10% in Victoria alone in the first year of the pandemic. In 2021, referrals to the Peter MacCallum Cancer Centre, a leading treatment and research facility in Melbourne, were down 40%. “That is certainly going to bounce back at some point,” says Prof Sherene Loi, an oncologist and researcher at Peter MacCallum. “It is potentially going to be a real problem in a few years’ time. At the moment we have a lot of very young cancer diagnoses, a lot of breast cancer … we are just flat chat.” Read full Source: The Guardian, 13 February 2022
  5. Content Article
    Cervical cancer symptoms include vaginal bleeding that is unusual for you, changes to vaginal discharge, discomfort during sex and pain in your lower back or pelvis. If you have symptoms, you should contact your GP.
  6. Content Article
    This article by the Royal College of Obstetricians & Gynaecologists and The My Body Back Project provides tips for healthcare professionals to make cervical cancer screening attendees feel as comfortable as possible during their appointments. Cervical screening can be very daunting for some women, and for those who have experienced sexual violence it can be triggering and cause emotional distress. The article provides the following tips, with more detailed guidance: Communication – language and listening - build trust by listening and acknowledging rather than downplaying any concerns. A sense of calm – how can you can make the environment feel calm and safe? Share control – Consider how you can demonstrate shared control within the consultation and examination. Position – a good position can make all the difference to their comfort and your ability to visualise the cervix. It’s about time…. Offer a double appointment so there is time to check in, build trust and for the woman or person with a cervix to feel ready to be examined.
  7. News Article
    Changes in cervical cancer screenings will help save lives, not put them at risk, according to a top gynaecologist. Prof Alison Fiander said people should not be worried screenings have dropped from every three to every five years in Wales as tests are "more effective". Public Health Wales (PHW) said the new rules were for people aged 25 to 49. More than 1.2 million people backed calls for a rethink in a UK petition and politicians in Wales will debate it after 30,000 signed a Senedd petition. Women and people with a cervix - as it could also affect trans men too - who had not tested positive for human papillomavirus (HPV) will now wait two more years between tests. Health chiefs in Wales said they changed the interval between screenings to the same time as those in Scotland because tests are now more accurate. Cervical screening gaps in England and Northern Ireland remain at three years. But Wales' public health body did publicly apologise for causing "concern", and admitted health chiefs "hadn't done enough to explain the changes". Prof Fiander, a clinical lead at the Royal College of Obstetricians and Gynaecologists, said PHW had "missed an opportunity" to help educate people but reassured the public the change was safe and not a cost-cutting exercise. Read full story Source: BBC News, 18 January 2022
  8. Content Article
    Today, 11 January 2022, the Less Survivable Cancers Taskforce (LSCT) launches its first ever Less Survivable Cancers Awareness Day, to raise the profile of these cancers and to highlight the critical importance of early diagnosis in improving survival.
  9. News Article
    An urgent debate has been called in the Senedd over a move to extend routine cervical screenings in Wales from every three years to five years. Public Health Wales (PHW) said those aged 25-49 who had not tested positive for human papillomavirus (HPV) would now wait two more years between tests. PHW said it was because the screening tests are now more accurate. However, 30,000 people signed a petition against it, citing the risk it could cause an increase in deaths. Particularly concerned are those who have not received the HPV vaccine, a national immunisation programme for which began in 2008 for girls aged 12 to 13. The number of signatures on the official petition on the Welsh Parliament's website was more than enough to trigger the issue to be looked at. The change follows a recommendation from the UK National Screening Committee. Last week, Public Health Wales apologised for causing "concern" over how it explained changes to screenings following its announcement. Read full story Source: BBC News, 10 January 2022
  10. News Article
    Screening for prostate cancer could be possible in the next five years, according to one of the UK's leading experts. Prof Ros Eeles, from the Institute of Cancer Research, said advances in genetics and medical imaging were making it possible. About 50,000 people in the UK are diagnosed with the disease each year, and nearly 12,000 die. NHS England said prostate screening had been notoriously tricky. Despite it being one of the most common cancers, there is no equivalent of the regular mammograms that detect breast cancer. There is a blood test that looks for levels of a protein called prostate specific antigen (PSA). But it is controversial and the UK's National Screening Committee does not recommend it. PSA tests are used to guide doctors and help monitor tumours. But using them to screen healthy people means they miss some cancers and cannot distinguish between people with high PSA levels who need treatment and those who do not. Read full story Source: BBC News, 27 December 2021
  11. Content Article
    Gomes et al. report the utilisation and impact of a novel triage-based electronic screening tool (eST) combined with clinical assessment to recognise sepsis in paediatric emergency department. An electronic sepsis screening tool was implemented in the paediatric emergency departments of two large UK secondary care hospitals between June 2018 and January 2019. Patients eligible for screening were children < 16 years of ages excluding those with minor injuries or who were brought directly to resuscitation.  Utilisation of a novel triage-based eST allowed sepsis screening in over 99% of eligible patients. The screening tool showed good accuracy to recognise sepsis at triage in the ED, which was augmented further by combining it with clinician assessment. The screening tool requires further refinement through multicentre evaluation to avoid missing sepsis cases.
  12. News Article
    A trial testing for Group B Strep during pregnancies has been welcomed by a mum who lost her son to the bacterial infection. The trial at Derriford Hospital will see routine testing for the bacteria that can put newborns at risk. Dawn Byly lost her third child Leo to the infection a day after he was born in Truro in 2003. "I would love to think this might help prevent other families going through such a traumatic loss," she said. About one in four pregnant women are carriers of Group B Strep. Most do not have any symptoms, but it can spread to their child during labour and in a small number of cases the infection can be life-threatening. Currently only women identified as being at risk are tested and if positive are offered antibiotics during labour and birth. Tests are available privately and involve a late swab in pregnancy. "Suffering the loss of a child is a tragedy and we are committed to making sure all women get the right support and best possible maternity care," said the Department of Health and Social Care. "The UK National Screening Committee reviewed the evidence to screen for Group B Strep at 35 to 37 weeks of pregnancy in 2017 and concluded there was insufficient evidence to introduce a national screening programme," it added. Dr Alexander Taylor, from Derriford Hospital in Plymouth, said: "It's felt uncomfortable as an obstetrician in the UK knowing America, Canada and many of our European neighbours have been routinely screening for Group B Strep. "This large trial aims to uncover both the clinical effectiveness but also the cost effectiveness of instituting a programme like this." Read full story Source: BBC News, 9 November 2021
  13. News Article
    About a third of NHS trusts in England are using “technically obsolete” imaging equipment that could be putting patients’ health at risk, while existing shortages of doctors who are qualified to diagnose and treat disease and injuries using medical imaging techniques could triple by 2030. According to data obtained through freedom of information requests by Channel 4’s Dispatches programme, 27.1% of trusts in NHS England have at least one computerised tomography (CT) scanner that is 10 years old or more, while 34.5% have at least one magnetic resonance imaging (MRI) scanner in the same category. These are used to diagnose various conditions including cancer, stroke and heart disease, detect damage to bones and internal organs, or guide further treatment. An NHS England report published last year recommended that all imaging equipment aged 10 years or older be replaced. Software upgrades may not be possible on older equipment, limiting its use, while older CT scanners may require higher radiation doses to deliver the same image, it said. Dr Julian Elford, a consultant radiologist and medical director at the Royal College of Radiologists (RCR), said: “CT and MRI machines start to become technically obsolete at 10 years. Older kit breaks down frequently, is slower, and produces poorer quality images, so upgrading is critical." “We don’t just need upgraded scanners, though; we need significantly more scanners in the first place. The [NHS England report] called for doubling the number of scanners – we firmly support that call, and recommend a government-funded programme for equipment replacement on an appropriate cycle so that radiologists can diagnose and treat their patients safely." Read full story Source: The Guardian, 18 October 2021
  14. Content Article
    The Healthcare Safety Investigation Branch (HSIB) identified a patient safety risk caused by delays in diagnosing lung cancer. Lung cancer is the third most common cancer diagnosed in England, but accounts for the most deaths. Two-thirds of patients with lung cancer are diagnosed at an advanced stage of the disease when curative treatment is no longer possible, a fact which is reflected in some of the lowest five-year survival rates in Europe. Chest X-ray is the first test used to assess for lung cancer, but about 20% of lung cancers will be missed on X-rays. This results in delayed diagnosis that will potentially affect a patient’s prognosis. The HSIB investigation reviewed the experience of a patient who saw their GP multiple times and had three chest X-rays where the possible cancer was not identified. This resulted in an eight-month delay in diagnosis and potentially limited the patient’s treatment options.
  15. News Article
    A review of the work of a former locum consultant radiologist in the Northern Trust has identified major discrepancies in 66 images. The trust has concluded a review of 13,030 scans and x-rays. The review was launched in June after the General Medical Council raised concerns about the locum consultant radiologist's work. The highest level of hospital investigation will be carried out into the cases of 17 patients. More than 9,000 patients were contacted as part of the review. The review identified six images at level one - a major discrepancy where errors or omissions in reporting could have had an immediate and significant clinical impact for the patients concerned. A further 60 images were level two - a major discrepancy with a probable clinical impact. "Most of the images categorised as having Level 1 and Level 2 discrepancies are CT scans but some are MRI scans, chest x-rays and other x-rays," said the trust's medical director, Seamus O'Reilly. "That detailed clinical assessment, which has resulted in 69 patients being called back, was to determine whether any clinical harm occurred as a result of the discrepancies found in the lookback review," "I can confirm that following careful consideration, the clinical assessment group has determined that 17 patients should now be part of a Level 3 Serious Adverse Incident (SAI) review." Read full story Source: BBC News, 13 October 2021
  16. Content Article
    Diabetic eye screening (DESP) is a national programme which is designed to pick up changes in the retina, at the back of the eye, in people with diabetes. These changes, known as diabetic retinopathy, are usually detected long before eyesight is affected. The goal of screening is to find people with sight threatening retinopathy, so that advice and treatment can be offered to prevent sight loss, as diabetic retinopathy is one of the leading causes of blindness in the UK. In this presentation, Dr Elizabeth Wilkinson, Clinical Lead Devon DESP, discusses harm in diabetic eye screening,what a clinical harm review is and communication, including Duty of Candour.
  17. News Article
    The number of women in the UK who have not had vital NHS breast screening, which can stop people dying from breast cancer, has risen by an estimated 50% - to nearly 1.5 million women - since services resumed, the leading UK breast cancer charity warns during Breast Cancer Awareness Month. Breast Cancer Now reveals an alarming increase of around half a million women who haven’t been screened since services restarted in summer 2020, estimating that around 1,480,000 fewer women in the UK had breast screening between March 2020 and May 2021, compared to pre-pandemic levels. This comes a year after the charity reported that almost one million women had missed breast screening due to COVID-19 seeing services paused. According to the charity, nearly 12,000 people in the UK could have been living with undiagnosed breast cancer at the end of May 2021, due to the impact of the pandemic on breast screening services and fewer women being referred to specialists with possible symptoms of the disease since March 2020 – a frightening prospect when early detection can stop people dying from the disease. Full article here Source: Breast Cancer Now Also covered in the Independent
  18. News Article
    Screening smokers and ex-smokers could dramatically reduce deaths from lung cancer – Britain’s biggest cancer killer – a major new study has found. Low-dose computerised tomography (CT) scans can detect tumours in people’s lungs early and cut deaths by 16%, according to the UK Lung Cancer Screening Trial (UKLS). The findings have prompted renewed calls from lung cancer experts for the government to bring in routine screening across the UK of all those who are at risk because of their smoking history. They say that early detection means patients can have potentially curative surgery or radiotherapy. “Lung cancer early detection and surgical intervention saves lives,” said Professor John Field of Liverpool University, an author of the trial. Read full story Source: The Guardian, 12 September 2021
  19. News Article
    A review into the work of a locum consultant radiologist has so far identified "major discrepancies" affecting 12 cases. A full lookback review of 13,030 radiology images was launched last month. The doctor worked at hospitals run by the Northern Health Trust between July 2019 and February 2020. The review steering group chair said it was "images in levels one and two that we are most concerned about". "To date there are 12 level ones and twos [approximately 0.5% of the total number reviewed]," said Dr Seamus O'Reilly, the Northern Trust medical director. "Most of these concern CT scans where inaccurate initial reading of the scans could, or is likely to, have had an impact on the patient's clinical treatment and outcome." More than 9,000 patients have been contacted as part of the review, which is looking at radiology images taken in Antrim Area, Causeway, Whiteabbey and Mid Ulster Hospitals as well as the Ballymena Health and Care Centre. Read full story Source: BBC News, 28 July 2021
  20. Event
    until
    In September 2020 the UK Government announced the winners of its first Artificial Intelligence (AI) in Health and Care Awards and Kheiron's bid was successful. The funding that's been won will accelerate the roll out and rapid adoption of Mia (Mammography Intelligent Assessment) to address critical workforce challenges in NHS breast screening services in the UK. Kheiron is using the next 3 years to technically deploy and generate the evidence that our AI tool (Mia) can be safely adopted as the second reader in the breast screening workflow. They will be doing this across 15 NHS Breast Screening sites in the UK to prove generalisability. The tool will need to work for any woman, anywhere. This webinar presents an opportunity to find out more about the strategic context of the work with talks from the national leads at NHSEI and NHSx backing the project, clinicians helping to run the research and Kheiron itself on what we hope to achieve. Register
  21. Content Article
    Group B Streptococcus (Group B Strep, Strep B, Beta Strep, or GBS) is a type of bacteria which lives in the intestines, rectum and vagina of around 2-4 in every 10 women in the UK (20-40%). Most women carrying GBS will have no symptoms and although it is not harmful to pregnant women, it can affect babies around the time of birth. Read Poppy's story.
  22. Content Article
    Group B Streptococcus (GBS, group B Strep or Strep B) is a type of bacteria which lives in the intestines, rectum, or vagina of 2 to 4 in every ten women in the UK (20 to 40%). This is often referred to as ‘carrying’ or being ‘colonised with’ group B Strep.  Most women carrying GBS will have no symptoms. Carrying GBS is not harmful to you, but there is a small chance it can affect your baby around the time of birth. GBS can occasionally cause serious infection in young babies and, very rarely, in babies before they are born. Carrying GBS can also sometimes lead to serious infections for pregnant women, though this is also rare. Find out more about Group B Strep in pregnancy on the Group B Strep Support website or by watching the video via the link below. 
  23. News Article
    It was 4am on a Sunday in San Antonio, US, when Dana Jones heard an ominous sound, barely audible over the whirring of box fans, like someone struggling to breathe. She ran down the hall and found her daughter Kyra, age 12, lying on her back, gasping for air. Terrified, she called 911. A police officer, the first to arrive, dashed into Kyra’s bedroom, threw the slender girl over his shoulder and laid her on a leather sofa in the living room. He asked her mother, an oral surgery technician, to give her CPR. Kyra’s lips were ice-cold. An ambulance whisked the girl to Methodist Children’s Hospital, where staff members swarmed her and put her into a medically induced coma. Kyra, who has sickle cell, had suffered a devastating stroke — her second — a common complication of this inherited disease, which afflicts 100,000 Americans, most of them Black. She most likely would never have had the strokes if she had been given an annual screening test and treatment proven more than two decades earlier to prevent 9 out of 10 strokes in children with the disease and recommended by the National Institutes of Health. But like countless other children with sickle cell, she was never screened. Read full story Source: New York Times, 23 May 2021
  24. News Article
    Many dread being invited for their cervical smear test - but Laurie Hodierne found it exhausting to have to keep asking for appointments, and trying to chase up the result. He is one of a number of transgender men who still have a cervix but are no longer registered as female at their GP surgery. Laurie was re-registered as male without requesting it, he says. And this means he could miss out on potentially life-saving cervical smear tests because he is not automatically called up for screenings. As a doctor, Laurie worries others who might be less able to navigate the health system will simply give up trying to get their smear test. "I understand how the systems work and the language - and despite all of that I find it exhausting," he says. "You keep coming up against a brick wall. It's a healthcare inequality in the sense that you aren't able to get access to the screening programme in the same way." NHS patients registered as female are invited to a cervical-cancer screening every three years between the ages of 25 and 50, and then every five years until they are 65. But anyone who has a cervix can develop cervical cancer. The disease often has no symptoms in its early stages and can be fatal. Read full story Source: BBC News, 17 May 2021
  25. Content Article
    Public Health England have developed a support page for people who find it difficult to attend cervical screening (a smear test). Some people feel anxious about attending because of: mental health issues previous traumatic experiences sexual abuse. The below link takes you to a webpage which outlines the support that is available if you feel anxious about attending cervical screening. You can use this information to help decide whether to attend, and to plan for your screening appointment.
×
×
  • Create New...